mitomycin a has been researched along with Pseudomyxoma Peritonei in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chua, TC; Liauw, W; Morris, DL; Zhao, J | 1 |
1 other study(ies) available for mitomycin a and Pseudomyxoma Peritonei
Article | Year |
---|---|
Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate.
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Chi-Square Distribution; Cohort Studies; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Kaplan-Meier Estimate; Laparotomy; Male; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Perioperative Care; Peritoneal Neoplasms; Peritoneum; Postoperative Complications; Prognosis; Pseudomyxoma Peritonei; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Treatment Outcome | 2011 |